Share
Share
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond.
Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH) Coordination, Data Analysis, and Technical Support IDIQ. This IDIQ provides services for NCI CGH through technical support for their research, coordination, and evaluation activities; data and portfolio analysis; production of accompanying reports; and science and technical writing, presentations, and documentation. The IDIQ contract ceiling is $9.9 million.
“We are excited by this opportunity to support the important work of the NCI and CGH’s cancer control initiatives directly. This work is a natural extension of our strong record of clinical research network coordination, cancer epidemiology, and international collaboration,” said John Graff, PhD, the Arbor Research Project Director, and cancer epidemiologist.
Immediately, Arbor Research will launch two task orders for NCI.
Global Cancer Research and Control Seminar Series (GCRCSS): Arbor Research will provide logistics, planning, execution, and post-event services for the GCRCSS.
Logistical and Technical Support for Implementation Science Consortium Activities (ICSA): Arbor Research will implement qualitative and quantitative analytic research studies, including provide study design, build data collection tools and web-based surveys, perform data analyses, and disseminate study results via reports, scientific and public presentations, and peer-reviewed manuscripts
Arbor Research partnered with Synergy Enterprises for this IDIQ pursuit.
“This award is a testament to our ongoing commitment to delivering innovative, impactful research that addresses critical global cancer control challenges, while providing value and agility to NCI’s mission,” said Christopher Spera, PhD, President and CEO of Arbor Research.
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen […]
Arbor Research Collaborative for Health, a Michigan-based 501(c)3 nonprofit corporation, is proud to announce the award of the General Services Administration (GSA) Multiple Award Schedule contract to its subsidiary, Arbor Research LLC under SINs 541611 and 541715. Arbor Research LLC qualifies as a small business under the associated NAICS codes and will seek additional SINs […]
A newly published article in the American Journal of Kidney Diseases, titled “Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS),” reveals significant findings on the factors contributing to improved patient survival rates among hemodialysis patients worldwide. The study, led by Arbor Research […]